Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 25 ... to recent research from the United States, "A method to estimate the boundary of a tumor using an interstitial microwave probe was evaluated in numerical and phantom models. ... may also be applicable in other situations that contain dielectric contrast between a volume of tissue and its background, such as monitoring tumor ablation growth," wrote P. Wang ...
2009 NOV 17 ... achieved subtotal resection. Two patients have been performed biopsy because of giant tumor volume. One patient has been partially resected for internal carotid artery involved. The ...
2009 NOV 23 ... had seminal vesicle/lymph node involvement and 7 (15%) had positive margins. Mean total tumor volume was 1.3 cm(3) (range 0.02 to 10.8). Of the 48 tumors 13 (27%) were potentially ...
2009 NOV 23 ... physician to control and adjust the treatment in real time to ensure that the targeted tumor is fully treated and surrounding tissue is spared. ExAblate received the CE Mark for ... recovery time than hysterectomy. A separate study shows the positive correlation in the volume reduction of the fibroid to symptom improvement after two years, while a third showed ...
2009 NOV 23 ... physician to control and adjust the treatment in real time to ensure that the targeted tumor is fully treated and surrounding tissue is spared. ExAblate received the CE Mark for ... recovery time than hysterectomy. A separate study shows the positive correlation in the volume reduction of the fibroid to symptom improvement after two years, while a third showed ...
2009 NOV 23 ... into tumor tissues and remarkably improved antitumor efficacy of paclitaxel. The average tumor volume in the HFT-T treatment group was 92.9 +/- 78.2 mm(3) vs 1670.3 +/- 286.1 mm(3) in the ...
2009 NOV 23 ... C4-2B CaP cells and treated with HE3235. Serum prostate-specific antigen (PSA) levels, tumor volume, immunohistochemistry, gene expression, and levels of intratumoral androgens were ...
2009 NOV 23 ... node metastasis in our cohort remained free of recurrence during followup. Extravesical tumor extension and lymph node density greater than 4% were associated with a higher ... the Journal of Urology report. "We examined outcomes in patients with low volume lymph node metastasis and identified variables associated with disease recurrence. Our ...
2009 NOV 23 ... has been observed in other model systems, including graft-vs-host disease (GVHD) and tumor development." "However, the mechanisms involved in this phenomenon remain ... of HGF into mice implanted with mammary tumors resulted in normalization of thymic volume and levels of VEGF, IL-7 and IL-15. While, injections of IL-7 partially restored the ...
2009 NOV 23 ... administered over long periods of time, and result in disease stabilization rather than tumor shrinkage." "The activity of these novel agents might, therefore, be ... reflected by changes in molecular features of the tumor rather than reduction in size or volume. Thus, noninvasive procedures to measure such features are urgently needed. Factors that ...
2009 NOV 17 ... breasts were used." "In each breast phantom an artificial nonpalpable ''tumor'' was created by injecting an aqueous gel containing gadolinium. MRgFUS (n = 7) was ... margins (negative/positive), minimum tumor-free margin (mm), and excised tissue volume (cm(3)). With MRgFUS localization no positive margins were found after excision (0%). ...
2009 NOV 23 ... the bone marrow, spleen, liver, and lymph nodes were extensively infiltrated by atypical tumor cells with occasional bi-or multi-lobated nuclei. They were positive for mast cell ... died of multi-organ failure with rapidly progressing hepatosplenomegaly and large-volume ascites 3 months after admission. At autopsy the bone marrow, spleen, liver, and lymph ...
2009 NOV 23 ... units, RapidArc treatments were found to conform to the shape and size of a targeted tumor at least as well as dynamic, fixed-beam approaches to IMRT, SRS, and SRT. "Treatment ... 51st Annual Meeting," International Journal of Radiation Oncology, Biology, Physics, Volume 75, Issue 3, Supplement . *One member of the UCI research team received a ...
2009 NOV 23 ... BLI signals have been found to correlate well with magnetic resonance measurements of tumor volume. However, in our studies of small-animal models of malignant brain tumors, we have ...
2009 NOV 23 ... 1.65 months) than low grade tumors (average 11.2 months) (P = 0.05). MRI revealed tumor (8 cervical, 17 thoracic, 7 lumbar, 7 sacral) volumes of 98-94,080 mm(3) (average 19,474 ... with lower grade pathology (P = 0.003). There was no correlation between tumor grade and volume (P = 0.63) or edema (P = 0.36) by MRI analysis. Median survival was 53 months and was ...
2009 NOV 23 ... series was 100%, 88.9% and 88.9% at 1, 3 and 5 years, respectively. Localized solid tumor progression was seen in two patients. Cyst progression was noted in three of nine ... radiation therapy had failed in six patients. The median radiosurgery target volume was 4.7 cc (range, 0.6-33.7 cc) and the median margin dose was 13.3 Gy (range, 10-20 ...
